Omalizumab Injection Market Outlook: Trends Driving the Future of Targeted Biologic Therapies
The Omalizumab Injection Market is witnessing a robust surge as the global prevalence of allergic asthma and chronic idiopathic urticaria continues to rise. Omalizumab, a monoclonal antibody targeting immunoglobulin E (IgE), has become a cornerstone therapy for patients unresponsive to conventional treatments. The increasing clinical adoption of biologic therapies, coupled with a growing...
0 Σχόλια 0 Μοιράστηκε 8 Views 0 Προεπισκόπηση